Waverley Pharma Competitors and Similar CompaniesClear all
Puma Biotechnology's competitors and similar companies include Progenics Pharmaceuticals.
 Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. |  Progenics Pharmaceuticals Progenics Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapeutics for cancer patients. | |
Founding Date | Founding Date 2010 | Founding Date 1986 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Los Angeles, US HQ | Locations New York, US HQ Billerica, US |
Employees | Employees 27214% decrease | Employees 49 |
Financial | ||
Revenue (est.) | Revenue (est.) $228.4m (FY, 2025) | Revenue (est.) $35m (FY, 2019) |
Cost of goods | Cost of goods $58.2m (FY, 2025) | Cost of goods $3.2m (FY, 2019) |
Gross profit | Gross profit $170.2m (FY, 2025) | Gross profit $31.8m (FY, 2019) |
For sources of this data, please see the company profile
View Company Profiles
Progenics Pharmaceuticals
HQ
New York, US
Progenics Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapeutics for cancer patients.
View company